Verkazia Emulsion
Product Images NDC 82667-014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Verkazia (NDC 82667-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Verkazia-carton (Verkazia Carton)

Verkazia-carton (Verkazia Carton)
This is the packaging label for Verkazia cyclosporine ophthalmic emulsion 0.1%, an ophthalmic topical human prescription drug. The label shows 120 single-use 0.3 mL vials. It includes instructions for use, storage information, and contact details for Harrow Eye, LLC, the labeler. The design features green and white backgrounds with product information prominently displayed.*
FDA Label Image

Structural Formula (Verkazia 01)

Structural Formula (Verkazia 01)
Chemical structure diagram of cyclosporine, the active ingredient in Verkazia ophthalmic emulsion. The diagram shows the molecular arrangement including carbon, hydrogen, nitrogen, and oxygen atoms with associated bonds forming the cyclosporine molecule.*
FDA Label Image

Table 2 (Verkazia 02)

Table 2 (Verkazia 02)
A data table comparing Vehicle, Verkazia QID, and Verkazia BID groups at Baseline and monthly visits up to Month 4, showing numerical values with standard deviations. Adjacent is a 95% confidence interval plot favoring Verkazia QID over Vehicle, depicting the difference in measured outcomes at each visit.*
FDA Label Image

Table 3 (Verkazia 03)

Table 3 (Verkazia 03)
A data table comparing mean values with standard deviations across different visits (Baseline to Month 4) for three groups: Vehicle (N=58), Verkazia QID (N=56), and Verkazia BID (N=54). A graphical display shows 95% confidence intervals for differences between Verkazia QID and Vehicle, favoring Verkazia QID with values ranging approximately from -15.7 to -18.9.*
FDA Label Image

Figure A (Verkazia 04)

Figure A (Verkazia 04)
An instructional illustration depicting two hands holding and twisting a cap off a small ophthalmic dropper bottle. This image likely demonstrates how to open the bottle before use.*
FDA Label Image

Figure B (Verkazia 05)

Figure B (Verkazia 05)
An instructional illustration showing a person administering a liquid drop from a dropper into their eye. One hand holds the dropper above the open eye, while the other hand gently pulls down the lower eyelid to create a small pocket for the drop.*
FDA Label Image

Figure C (Verkazia 06)

Figure C (Verkazia 06)
An instructional illustration showing a person tilting their head back and using a finger to pull down the lower eyelid, preparing to apply an ophthalmic product such as eye drops or an emulsion to the eye.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.